SPX3,911.74+116.01 3.06%
DIA315.02+8.28 2.70%
IXIC11,607.62+375.43 3.34%

BRIEF-Eledon Pharmaceuticals Announces Orphan Drug Designation Granted To Tegoprubart

reuters.com · 06/09/2022 08:04
BRIEF-Eledon Pharmaceuticals Announces Orphan Drug Designation Granted To Tegoprubart

- Eledon Pharmaceuticals Inc ELDN:

  • ELEDON PHARMACEUTICALS ANNOUNCES ORPHAN DRUG DESIGNATION GRANTED TO TEGOPRUBART FOR THE PREVENTION OF ALLOGRAFT REJECTION IN PANCREATIC ISLET CELL TRANSPLANTATION

Source text for Eikon: ID:nGNX7p2x3p

Further company coverage: ELDN


((reuters.briefs@thomsonreuters.com;))